• FDA Calls for Withdrawal of Multiple Myeloma Drug Pepaxto

    1 month ago - By Medscape

    The drug was granted an accelerated approval, but a confirmatory phase 3 trial raised concerns about safety after showing higher mortality than in the comparator arm.
    News Alerts
    Read more ...